Revision history of "Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections" (Q39437895)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

6 February 2023

14 November 2022

10 July 2021

9 July 2021

16 November 2019

20 March 2019

10 March 2019

  • curprev 06:5806:58, 10 March 2019 Emijrpbot talk contribs 34,337 bytes +4,822 Updated Item: BOT - Adding descriptions (57 languages): ar, ast, bg, bn, ca, cs, da, de, el, eo, es, et, fa, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cyrl, th, tl, tr, ur, vi, wuu, yue, zh, zh-cn, zh-hans, zh-hant, zh-hk, zh-mo, zh-my, zh-sg, zh-tw undo (restore)

13 November 2018

2 October 2018

9 January 2018

12 September 2017